Natural Therapeutics in Non-Alcoholic Fatty Liver Disease: A Comprehensive Review

Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), represents the hepatic manifestation of metabolic syndrome and is the leading cause of chronic liver disease globally. The disease spectrum extends from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH), progressive fibrosis, cirrhosis, and hepatocellular carcinoma. Given the multi-targeted pathomechanisms of NAFLD—including insulin resistance, lipid dysregulation, oxidative stress, and pro-inflammatory signaling—herbal therapeutics have gained substantial interest. Plants belonging to the genus Ficus (family Moraceae), notably Ficus amplissima, are rich sources of bioactive flavonoids, polyphenols, and terpenoids that exhibit protective metabolic effects. This review synthesizes current insights into the pathophysiology of NAFLD, evaluates natural dietary and herbal interventions, and highlights the therapeutic mechanisms of Ficus amplissima in mitigating hepatic steatosis, dyslipidemia, oxidative stress, and structural liver injury.

Authors

Publication Details

Journal
International Journal of Medical & Pharmaceutical Sciences
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24413579
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Natural Therapeutics in Non-Alcoholic Fatty Liver Disease: A Comprehensive Review

Arshi Khan*1, Richa Agarwal2, Rajesh Asija3
International Journal of Medical & Pharmaceutical Sciences
Liver Disease Diagnosis and Treatment
article

Natural Therapeutics in Non-Alcoholic Fatty Liver Disease: A Comprehensive Review

Arshi Khan*1, Richa Agarwal2, Rajesh Asija3
article en

Abstract

Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), represents the hepatic manifestation of metabolic syndrome and is the leading cause of chronic liver disease globally. The disease spectrum extends from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH), progressive fibrosis, cirrhosis, and hepatocellular carcinoma. Given the multi-targeted pathomechanisms of NAFLD—including insulin resistance, lipid dysregulation, oxidative stress, and pro-inflammatory signaling—herbal therapeutics have gained substantial interest. Plants belonging to the genus Ficus (family Moraceae), notably Ficus amplissima, are rich sources of bioactive flavonoids, polyphenols, and terpenoids that exhibit protective metabolic effects. This review synthesizes current insights into the pathophysiology of NAFLD, evaluates natural dietary and herbal interventions, and highlights the therapeutic mechanisms of Ficus amplissima in mitigating hepatic steatosis, dyslipidemia, oxidative stress, and structural liver injury.

International Journal of Medical & Pharmaceutical Sciences
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Natural Therapeutics in Non-Alcoholic Fatty Liver Disease: A Comprehensive Review — Arshi Khan*1, Richa Agarwal2, Rajesh Asija3 · International Journal of Medical & Pharmaceutical Sciences (2026) | TGRS Research Map | TGRS